187 related articles for article (PubMed ID: 18981708)
21. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
22. FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT.
Franzius C; Daldrup-Link HE; Sciuk J; Rummeny EJ; Bielack S; Jürgens H; Schober O
Ann Oncol; 2001 Apr; 12(4):479-86. PubMed ID: 11398879
[TBL] [Abstract][Full Text] [Related]
23. Radiation-induced osteosarcoma might mimic metastatic bone lesions: a case with bone scan and FDG PET/CT imaging.
Koyama M; Koizumi M; Umayahara K; Takeshima N; Takahashi S
Clin Nucl Med; 2015 May; 40(5):427-9. PubMed ID: 25608153
[TBL] [Abstract][Full Text] [Related]
24. (18)F-fluoride PET imaging in a nude rat model of bone metastasis from breast cancer: Comparison with (18)F-FDG and bioluminescence imaging.
Kang WJ; Song EH; Park JY; Park YJ; Cho A; Song HT
Nucl Med Biol; 2015 Sep; 42(9):728-33. PubMed ID: 26068116
[TBL] [Abstract][Full Text] [Related]
25. 18F-FDG PET/CT in a rare malignant extraskeletal osteosarcoma.
Cao Q; Lu M; Huebner T; Dilsizian V; Chen W
Clin Nucl Med; 2013 Sep; 38(9):e367-9. PubMed ID: 23856822
[TBL] [Abstract][Full Text] [Related]
26. Comparison of (18)F-FDG-PET/CT with (99m)Tc-MDP bone scintigraphy for the detection of bone metastases in cancer patients.
Ozülker T; Küçüköz Uzun A; Ozülker F; Ozpaçac T
Nucl Med Commun; 2010 Jun; 31(6):597-603. PubMed ID: 20224457
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis.
Franzius C; Sciuk J; Brinkschmidt C; Jürgens H; Schober O
Clin Nucl Med; 2000 Nov; 25(11):874-81. PubMed ID: 11079583
[TBL] [Abstract][Full Text] [Related]
28. Superiority of NaF PET/CT Over Chest CT in a Case of Osteosarcoma.
Morland D; Godard F; Lalire P; Eymard JC; Papathanassiou D
Clin Nucl Med; 2021 Jul; 46(7):584-585. PubMed ID: 33782283
[TBL] [Abstract][Full Text] [Related]
29. 18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.
Palaskas N; Larson SM; Schultz N; Komisopoulou E; Wong J; Rohle D; Campos C; Yannuzzi N; Osborne JR; Linkov I; Kastenhuber ER; Taschereau R; Plaisier SB; Tran C; Heguy A; Wu H; Sander C; Phelps ME; Brennan C; Port E; Huse JT; Graeber TG; Mellinghoff IK
Cancer Res; 2011 Aug; 71(15):5164-74. PubMed ID: 21646475
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
31. Exploration of Imaging Biomarkers for Metabolically-Targeted Osteosarcoma Therapy in a Murine Xenograft Model.
Huang S; Ren L; Beck JA; Phelps TE; Olkowski C; Ton A; Roy J; White ME; Adler S; Wong K; Cherukuri A; Zhang X; Basuli F; Choyke PL; Jagoda EM; LeBlanc AK
Cancer Biother Radiopharm; 2023 Sep; 38(7):475-485. PubMed ID: 37253167
[No Abstract] [Full Text] [Related]
32. Combined 18F-fluoride and 18F-FDG PET/CT scanning for evaluation of malignancy: results of an international multicenter trial.
Iagaru A; Mittra E; Mosci C; Dick DW; Sathekge M; Prakash V; Iyer V; Lapa P; Isidoro J; de Lima JM; Gambhir SS
J Nucl Med; 2013 Feb; 54(2):176-83. PubMed ID: 23243299
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of chemotherapy response in osteosarcoma with FDG-PET.
Hamada K; Tomita Y; Inoue A; Fujimoto T; Hashimoto N; Myoui A; Yoshikawa H; Hatazawa J
Ann Nucl Med; 2009 Jan; 23(1):89-95. PubMed ID: 19205843
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography for prostate, bladder, and renal cancer.
Schöder H; Larson SM
Semin Nucl Med; 2004 Oct; 34(4):274-92. PubMed ID: 15493005
[TBL] [Abstract][Full Text] [Related]
35. Is (99m)Tc-MDP whole body bone scintigraphy adjuvant to (18)F-FDG-PET for the detection of skeletal metastases?
Sahin E; Zincirkeser S; Akcan AB; Elboga U
J BUON; 2014; 19(1):291-6. PubMed ID: 24659678
[TBL] [Abstract][Full Text] [Related]
36. Diffuse Increased 68Ga-DOTATATE But Unimpressive 18F-FDG Osseous Activity in a Patient With Rapid-Progressing Synchronous Multifocal Osteosarcoma.
Qin C; Shao F; Lan X
Clin Nucl Med; 2020 Oct; 45(10):824-826. PubMed ID: 32796243
[TBL] [Abstract][Full Text] [Related]
37. 18F-NaF PET/CT Images of Cardiac Metastasis From Osteosarcoma.
Chou YH; Ko KY; Cheng MF; Chen WW; Yen RF
Clin Nucl Med; 2016 Sep; 41(9):708-9. PubMed ID: 27405028
[TBL] [Abstract][Full Text] [Related]
38. Unsuspected Metastases to Muscles in Osteosarcoma Detected on 18F-Sodium Fluoride PET-CT.
Usmani S; Marafi F; Rasheed R; Bakiratharajan D; Al Maraghy M; Al Kandari F
Clin Nucl Med; 2018 Sep; 43(9):e343-e345. PubMed ID: 30080191
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
40. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
Chua S; Gnanasegaran G; Cook GJ
Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
